Skip to Content »

Site Map

FREE Shipping: All Individuals in United States, Mexico, Central and South America & The Caribbean

Take 30 percent off your entire order. ☄ Disclaimer ☄* Offer valid 11/23/15 - 11/25/15. 30% discount applies to all Medical Reference and Textbooks, PDF, ePub & VST eBooks. This offer is not valid on Clinics Review Articles (individual issues and subscriptions), Journals, and Nursing and Health Profession Textbooks, Institutional Video Series, HESI Products, Kindle or Nook e-books, Pageburst titles, ClinicalKey packages, mobile apps, medical clothing or accessories, bulk or previous purchases, clearance titles, or in combination with any other promotion. Offer only valid for purchases by individual customers in U.S., Mexico, South and Central America and the Caribbean from Enter promotional code BBV4E16514 at checkout to receive your discount. This offer expires on November 25, 2015.

Clinical Lung Cancer

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.

Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: click here

View all Oncology titles

Related Links

Editor Information

    David R. Gandara

Impact Factor

* 2011 Journal Citation ReportsĀ®, published by Thomson Reuters

Customer Reviews

Clinical Lung Cancer
  • Journal
  • Imprint: ELSEVIER
  • ISSN: 15257304
  • 2014 Impact Factor: 3.104*